CRP and IL-1B Gene Polymorphisms and CRP in Blood in Periodontal Disease

INTRODUCTION

Periodontitis is a complex multifactorial disease, usually initiating late and progressing slowly to a chronic phenotype or severe periodontal disease (PD) that is promoted both by environmental factors like smoking, pathogenic bacteria and stress, and by genetic factors [1]. The pathogenesis of PD involves repeated attack of the subgingival bacteria and the host immune defences that result in an inflammatory process contributing to the periodontal tissue destruction. The periodontal structure is a site of unusual opportunity for pathogen attack with the non-shedding tooth surface allowing formation of persistent bacterial biofilms that can maintain proximity to the periodontal tissue [2, 3]. The initial and reversible gingivitis may develop to periodontitis with the periodontal ligament detaching from cementum to form periodontal pockets, and the damage extends further to cause alveolar bone resorption, gingival recession, tooth mobility and finally tooth loss. Of the over 300 bacterial species isolated from dental plaque, common Gram-negative species of the periodontal pockets include Aggregatibacter (previously Actinobacillus) actinomycetemcomitans, Porphyromonas gingivalis and Tannerella (previously Bacteroides) forsythus. However, while the bacterial interactions or bacterial plaque are required for the inflammatory condition, they do not explain all cases, for example when periodontitis is observed with little bacterial plaque, or no periodontitis in spite of heavy plaque. The progression and severity of the disease is affected by the strength of the host immune defences and other responses, and the variation in the susceptibility implies an effect of genetic factors [3, 4]. The multifactorial nature of the disease suggests multiple gene associations with a modest or weak individual influence that combined together with other factors have a significant effect on the variation of the manifested outcome [5]. Also other multifactorial diseases like cardiovascular disease (CVD) similarly involve chronic inflammation. CVD is caused by atherosclerosis (hardening) of blood vessels, the process through which deposit of fatty substances, cholesterol, cellular waste products, calcium and other substances build up in the inner arterial lining. The atherosclerotic plaque will cause symptoms and complications as a result of narrowing of the arterial lumen and narrowing of blood flow to the heart [6]. Epidemiological studies suggest an association between CVD and PD [2, 7, 8]. Suggested mechanisms that can result in such an association include common risk factors including smoking and infections that promote release of proinflammatory cytokines like interleukine-1 or IL-1, and genetic factors related to the regulatory networks of the inflammatory mechanisms [7, 9].

One sensitive marker of inflammation is C-reactive protein (CRP) that is produced particularly in the acute phase of inflammation, infection and trauma in response to pro-inflammatory cytokines like IL-1 and IL-6 [2]. Single nucleotide polymorphisms (SNP) of IL-1B gene, located on chromosome 2q13-q21 and which encode the IL-1β cytokine protein, have been reported to be associated with the baseline blood CRP levels of healthy individuals, and it has been suggested that IL-1B regulates the basal CRP levels [3]. Considering the documented evidence on the association between CVD and PD, with expected common genetic risk factors, it is of interest to explore the mechanisms of the association in further detail. The details can be expected to involve the IL-1B gene as one of the primary candidates, and possibly also the CRP gene that is expressed as C-reactive protein in the affected tissue, and in blood. The impact of the genetic variation of particular interest can be assessed by evaluating the polymorphism status in these genes within the population, which in the present case is Indonesian, with respect to the corresponding status of PD. With more detailed information on the mechanisms involved one can hope for improved predictors of risk to CVD, PD, and other systemic chronic disease, and possibly even for routes towards improved therapies.

This work aimed to evaluate the distribution of selected polymorphisms of IL-1B and CRP genes, and serum CRP level with respect to the PD status in a sample from the Indonesian population. Implications were also to be considered on predicting the risk to PD, based on the potential associations between the patterns of polymorphisms, serum CRP level, and the severity of PD.

MATERIALS AND METHODOLOGY

DNA Isolation, PCR Amplification and RFLP Genotyping

To survey the genotype-phenotype variations related to the gene locus polymorphisms of IL-1B and CRP, the polymorphism status of these genes was determined from samples of peripheral blood.

For isolation of DNA, 3 mL of peripheral blood was taken from each of the 101 subjects, placed in 15 mL tubes containing 9 mL of red blood lysis solution (1.45M NH₄Cl, 5mM anhydrous EDTA, and 0.1M KHCO₃) and incubated at room temperature for 10 min. The sample was then centrifuged at 1500 rpm for 10 min at room temperature, and the supernatant was removed to leave a precipitate of mononuclear leukocytes. These steps were repeated to obtain a white pellet and a supernatant containing no red blood cells. To this pellet 2 mL of cell lysis solution was added and pipetted until homogeneous, and incubated in a water bath at 37°C for 30-60 min until completely homogeneous. Then 1.3 mL of protein precipitation solution (5M ammonium acetate) was added, vortex mixed for 15-20 s and centrifuged at 3000 rpm for 15 min at 4°C, producing a light brown precipitate (proteins) and the supernatant containing DNA. The supernatant was poured into a new Falcon tube with 2.3 ml of cold isopropanol. The tube was inverted up to 20-30 times until showing a collection of DNA strands. The supernatant was removed and 1.3 mL of 70% ethanol was added for washing, and the DNA solution was centrifuged at 3000 rpm for 5 min at 4ºC. After discarding supernatant, the DNA was dried in open air by reversing the tube, then DNA was rehydrated with a solution of 200-300 uL TE (Tris-HCl EDTA) and incubated in a water bath at 37ºC for 2 h. The solution was transferred into 1.5 mL sterile microcentrifuge tubes and stored at -20°C until further examination.

PCR amplification of DNA fragments was carried out by using Perkin Elmer GeneAmp ® PCR System 9700 with PCR Master Mix, BiomixRed (Bioline). The DNA samples were amplified in 35 cycles of an initial denaturation at 94°C for 5 min and cycles of denaturation, annealing and elongation (primers and PCR optimization are shown in Table 1). The end of the cycle included an extension at 72°C for 7 min. After completion the amplicons were stored at 4°C.

Table 1.

Gene	Primers	PCR cycles
IL-1B	5’- CTCAGGTGTCCTCGAAGAAATCAAA-3' 5’- GCTTTTTTGCTGTGAGTCCCG-3'	35 cycles, 94°C(30"), 58°C(30"), 72°C(30")
CRP717	5'-ACTGGACTTTTACTGTCAGGGC -3' 5'-ATCCCATCTATGAGTGAGAACC-3'	35 cycles, 94°C(30"), 58°C(30"), 72°C(30")
CRP1444	5-AGCTCGTTAACTATGCTGGGGCA-3 5-CTTCTCAGCTCTTGCCTTATGAGT-3	30 cycles 94°C(30"), 62°C(30"), 72°C(30")

The polymorphisms of IL-1B, CRP717 and CRP1444 were analyzed with PCR-RFLP using the restriction enzymes TaqI, SacII and Bsp, respectively, for cutting at the sites of polymorphisms [3, 5]. For each amplicon to be cut, the corresponding restriction enzyme was added into 10 μL of the amplified DNA fragments, 2 μL buffer solution and 18 μL ddH₂O, incubated in water bath at 37ºC for 3 h and finally at 65 ºC for 20 min for enzyme inactivation. For fragment separation, 5 μL of the resulting product was mixed with 2 μL of tracking dye (0.25% bromophenol blue, 0.25% xylene xyanole, 25% sucrose) and subjected to electrophoresis on 3% agarose gel (Promega) containing 1 μL ethidium bromide (0.5 mg/mL) in 1X TAE buffer solution (0.04 M Tris-acetate, 0.002 M EDTA pH 8.0) at 90 V for 60 min. Using 100 bp DNA ladder markers (Promega), the results were inspected under UV illumination (UV Filter TM Spectroline) and recorded with a digital camera (Fig. 1).

RESULTS

The results are summarized in Table 2, where they are divided into groups of normal, moderate and severe periodontal disease. In this classification the normal cases included the lowest number of cases (11). The mean age was highest for the severe PD group, and for all groups SD is similar and also about the same as the difference between the means of the normal and severe PD groups. Of the subjects with severe PD, many fewer were non-smokers (28.6%) than smokers (71.4%). In contrast, 41.7% of subjects with moderate PD were non-smokers, and only 10.4% of the subjects in this group (38.1% in the severe PD group) were heavy smokers with lifetime exposure to at least 100,000 cigarettes. In the normal group, 63.6% of the subjects were non-smokers and none were heavy smokers. The median and range of lifetime exposure to smoking showed a systematic increase from normal periodontal health to moderate and severe PD groups (Fig. 2). The measured range in the serum levels of C-reactive protein varied between 0.1 and about 20 mg/L.

The most common type of IL-1B polymorphism was the one with common homozygotes (CC), at a frequency of more than 90% for all groups of PD severity. For the heterozygotes type (CT), three cases (7.1%) only appeared in the severe PD group, and for rare homozygotes (TT) only two cases (4.2%) in the moderate PD group. For CRP (717) polymorphism, the common homozygotes (SS) occurred at frequencies of 54.2%/59.5% in the moderate/severe PD groups, but at 90.9% frequency in the normal group. The heterozygotes (Ss) appeared at frequencies of 37.5% and 33.3% in the moderate and severe PD groups, respectively, but not at all in the normal group. The rare homozygotes (ss) were observed at fairly similar though slightly decreasing rates of 9.1%, 8.3%, and 7.2% in the normal, moderate and severe PD groups, respectively. For CRP (1444) polymorphism, the more common homozygotes (BB) appeared only at low and decreasing frequencies of 9.1%, 6.25% and 4.8% in the same grouping order, while the heterozygotes (Bb) occurred at a frequency of 90% or higher in all groups, but rare homozygotes (bb) not at all.

DISCUSSION

In this work the polymorphisms of IL-1B (3954) and CRP (717, 1444) genes have been compared to the periodontal health and serum CRP level of 101 Indonesian male subjects. This sample included relatively few normal (healthy) subjects in comparison with the number of those with moderate or severe PD; this largely reflects the unfortunately high prevalence of PD in the Indonesian population. The results show a clear and expected relationship between PD severity and smoking habit, so that severe PD was significantly associated with higher lifetime smoking exposure, and normal oral condition and moderate PD with non-smokers. Note however that there are clearly other significant contributing factors than smoking (e.g. individual performance levels oral hygiene and immune response), as is seenof oral hygiene and immune response), as is seen from the increasing scatter in the lifetime exposure with the severity of PD in Fig. (2). Also an expected association with age was seen, so that the mean age of the subjects with severe PD was higher than for those with normal oral health and moderate PD. However, the grouping of normal condition, moderate PD and severe PD was not significantly associated with the polymorphisms of IL-1B or CRP (1444) in the sample population. The only exception was CRP (717) where the heterogeneous type in normal subjects occurred at a significantly lower fraction of cases than in subjects with PD; even here, no significant difference was seen between subjects with moderate and severe PD. The levels of serum CRP were varying strongly in all groups of PD severity, but the fraction of subjects with serum CRP level above 3 mg/L was lower for cases of normal periodontal health than for cases of moderate or severe PD. A large scatter is not unexpected since inflammation other than that related to PD can have much influence on the serum CRP levels.

The pro-inflammatory IL-1B can be blocked with the IL-1 receptor antagonist IL-1Ra (anakinra) that has been approved for treatment of some chronic autoinflammatory diseases like rheumatoid arthritis [8]. Until recently the IL-1 family only consisted of two main members (IL-1A and IL-1B) but has considerably expanded to include at least 11 members of which some like IL-18, IL-36A, IL-36B, and IL-36G are also pro-inflammatory factors, and some others appear antagonist or anti-inflammatory (IL-1Ra, IL-36Ra, IL-37) or with unknown function (IL-38). With only partially known receptors and coreceptors, their overall roles remain to be described in detail but are likely to be fairly complex judging from the known signalling networks related of IL-1B [9]. The observed frequencies of IL-1B (3954) genotype CC (Table 2) were clearly higher (more than 90%) in this work for Indonesian male adults than what has been reported previously for European subjects [15].

Chronic periodontitis typically involves a persistent infection of the periodontal pocket by Gram-negative bacteria like A. actinomycetemcomitans. This micro-organism produces a leucotoxin that induces degranulation and lysis in human neutrophils, caspase-1 activation, and abundant secretion of IL-1β from human macrophages, promoting tissue destruction including loss of alveolar bone [9,10]. Therefore the periodontal induction of IL-1B activity by the bacterial leucotoxin largely explains tooth loss in advanced PD. With local periodontal inflammation mediated by IL-1β that also enters circulation, the observed association is perhaps to be expected with CVD, another chronic systemic disease promoted by pro-inflammatory cytokines [2,9,11,14]. Nevertheless, the reported association between PD and CVD, and associations with them and individual polymorphisms of IL-1 and CRP genes, can be diluted by the complex polygenic nature of the overall regulatory networks with a relatively small contribution by any single gene. If the associations between individual genes and their polymorphisms are relatively weak, this also means that the individual polymorphisms alone are not particularly powerful risk indicators to such disease. While the conventional indicators may remain more useful, like the directly measured extent of pocket depth and alveolar bone loss for PD, and high blood pressure, smoking, obesity, and CRP level for CVD, successful treatment of PD can reduce inflammation and circulating IL-1 and CRP levels, with potentially reduced risk to CVD [12,13,16,17]. Also, potential additional indicators like CRP (717) polymorphism status may serve as a complementary factor to the current array of standard indicators, at least if it can be in future more conveniently tested.

CONCLUSION

A significantly lower fraction of subjects with normal periodontal health than those with PD showed the heterogeneous type polymorphism of CRP (717) that hence may provide a complementary indicator of the risk to PD. In contrast, no significant association was found between periodontal health and the polymorphisms of IL-1B or CRP (1444) in the Indonesian male sample population. However, considering the currently available evidence [16-18], the association between PD and CVD appears to remain sufficient to justify informing patients with severe PD that they may have an increased risk of CVD.

As the number of the subjects with a normal periodontal health in this work was relatively small, confirmation with further study of a larger sample population is necessary.

REFERENCES